Ischemic Stroke as First Clinical Evidence of Malignancy-Associated Disseminated Intravascular Coagulation
DOI:
https://doi.org/10.24950/rspmi.301Keywords:
Adenocarcinoma of Lung, Blood Coagulation, Disseminated Intravascular Coagulation, Factor XII Deficiency, Ischemic StrokeAbstract
Disseminated intravascular coagulation (DIC) is an acquired clinical and laboratory syndrome that results in excessive and unregulated activation of the coagulation cascade. Although thrombotic manifestations are common, clinically significant cerebral arterial ischemia is rarely reported. We report the case of an 80-year-old man admitted for multifocal stroke, altered coagulation tests, and worsening renal function. After extensive investigation, the diagnosis of multisystem thrombosis in the context of chronic DIC was assumed. A lymph node biopsy documented lung adenocarcinoma metastasis. Therapeutic enoxaparin was started but the patient rapidly deteriorated and died. Thrombotic microangiopathies should be considered in the differential diagnosis of stroke, especially if multifocal and associated with ischemic manifestations in other organs. Chronic DIC can be secondary to mucin-producing solid adenocarcinomas and has been increasingly reported in stage IV lung cancer. The overall prognosis is poor, and anticoagulation is insufficient in the absence of treatment of the underlying disease.
Downloads
References
Levi M. Clinical characteristics of disseminated intravascular coagulation in patients with solid and hematological cancers. Thromb Res. 2018;164:S77- S81. doi: 10.1016/j.thromres.2018.01.016.
Adams HP. Cancer and Cerebrovascular Disease. Curr Neurol Neurosci Rep. 2019; 19:73. doi:10.1007/s11910-019-0985-0.
Chen W, He Y, Su Y. Multifocal cerebral infarction as the first manifestation of occult malignancy: Case series of trousseau’s syndrome and literature review. Brain Circ. 2018;4:65. doi:10.4103/bc.bc_1_18.
Levi M. Disseminated Intravascular Coagulation in Cancer: An Update. Semin Thromb Hemost. 2019; 45:342–7. doi:10.1055/s-0039-1687890
Kanaji N, Mizoguchi H, Inoue T, Tadokoro A, Watanabe N, Ishii T, et al. Clinical features of patients with lung cancer accompanied by thromboembolism or disseminated intravascular coagulation. Ther Clin Risk Manag. 2018;14:1361-1368. doi: 10.2147/TCRM.S164700.
Adelborg K, Larsen JB, Hvas A. Disseminated intravascular coagulation: epidemiology, biomarkers, and management. Br J Haematol. 2021; 192:803– 18. doi: 10.1111/bjh.17172.
Thachil J, Falanga A, Levi M, Liebman H, Di Nisio M. Management of cancer- -associated disseminated intravascular coagulation: guidance from the SSC of the ISTH. J Thromb Haemost. 2015; 13:671–5. doi: 10.1111/jth.12838.
Tang S, Daram SR, Wu R, Bhaijee F. Pathogenesis, Diagnosis, and Management of Gastric Ischemia. Clin Gastroenterol Hepatol 2014; 12:246- 52. doi: 10.1016/j.cgh.2013.07.025
Nakano K, Sugiyama K, Satoh H, Shiromori S, Sugitate K, Arifuku H, et al. Risk factors for disseminated intravascular coagulation in patients with lung cancer: Risk factors for DIC with lung cancer. Thorac Cancer. 2018; 9:931–8. doi:10.1111/1759-7714.12766.
Moiz B, Sadiq MW, Javed MA, Jafry BH, Anees M. Prolonged activated partial thromboplastin time secondary to factor XII deficiency in two surgical patients. Oxf Med Case Reports. 2021;2021:omaa146. doi: 10.1093/omcr/ omaa146.
National Organization for Rare Disorders (NORD). Factor XII Deficiency [Internet]. 2012. [Accessed on 24th oct 2021] Available from: rarediseases.org/ rare-diseases/factor-xii-deficiency/.
Vlagea A, Falagan S, Gutiérrez-Gutiérrez G, et al. Antinuclear antibodies and cancer: A literature review. Crit Rev Oncol Hematol. 2018, 127:42–9. 10.1016/j.critrevonc.2018.05.002.
Madrid FF, Maroun MC. Serologic laboratory findings in malignancy. Rheum Dis Clin North Am. 2011;37:507-25. doi: 10.1016/j.rdc.2011.09.006.
Abdel-Wahab N, Tayar JH, Fa'ak F, Sharma G, Lopez-Olivo MA, Yousif A, et al. Systematic review of observational studies reporting antiphospholipid antibodies in patients with solid tumors. Blood Adv. 2020; 4:1746–55. doi: 10.1182/bloodadvances.2020001557
Downloads
Published
How to Cite
License
Copyright (c) 2022 Medicina Interna
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna